Based on the aTyr Pharma Inc stock forecast from 0 analysts, the average analyst target price for aTyr Pharma Inc is not available over the next 12 months. aTyr Pharma Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of aTyr Pharma Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, aTyr Pharma Inc’s stock price was EUR 3.84. aTyr Pharma Inc’s stock price has changed by +32.41% over the past week, +34.27% over the past month and +228.21% over the last year.
No recent analyst target price found for aTyr Pharma Inc
No recent average analyst rating found for aTyr Pharma Inc
Company Overview aTyr Pharma Inc
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California. Read Less
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pul...Read More
Frequently Asked Questions About aTyr Pharma Inc (471A:F) Stock
Stock Target Advisor's fundamental analysis for aTyr Pharma Inc's stock is Very Bearish.
Unfortunately we do not have enough data on 471A:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 471A:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 471A:F's stock to indicate if its overvalued.
The last closing price of 471A:F's stock was EUR 3.84.
The most recent market capitalization for 471A:F is EUR 0.26B.
Unfortunately we do not have enough analyst data on 471A:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains aTyr Pharma Inc's stock.
As per our most recent records aTyr Pharma Inc has 56 Employees.
aTyr Pharma Inc's registered address is 10240 Sorrento Valley Road, San Diego, CA, United States, 92121.
You can get more information about it from aTyr Pharma Inc's website at https://www.atyrpharma.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About aTyr Pharma Inc (471A:F) Stock
Stock Target Advisor's fundamental analysis for aTyr Pharma Inc's stock is Very Bearish.
Unfortunately we do not have enough data on 471A:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 471A:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 471A:F's stock to indicate if its overvalued.
The last closing price of 471A:F's stock was EUR 3.84.
The most recent market capitalization for 471A:F is EUR 0.26B.
Unfortunately we do not have enough analyst data on 471A:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains aTyr Pharma Inc's stock.
As per our most recent records aTyr Pharma Inc has 56 Employees.
aTyr Pharma Inc's registered address is 10240 Sorrento Valley Road, San Diego, CA, United States, 92121.
You can get more information about it from aTyr Pharma Inc's website at https://www.atyrpharma.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 471A:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
